rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1993-10-1
|
pubmed:abstractText |
The failure rate with radiation therapy alone for Stage III cervical cancer is quite high, and therefore other modalities are being pursued as adjuvants to radiation therapy in hopes of improving the results.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
72
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1949-54
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:8364872-Adjuvants, Immunologic,
pubmed-meshheading:8364872-Adult,
pubmed-meshheading:8364872-Aged,
pubmed-meshheading:8364872-Carcinoma, Squamous Cell,
pubmed-meshheading:8364872-Chemotherapy, Adjuvant,
pubmed-meshheading:8364872-Combined Modality Therapy,
pubmed-meshheading:8364872-Female,
pubmed-meshheading:8364872-Fever,
pubmed-meshheading:8364872-Humans,
pubmed-meshheading:8364872-Lactobacillus casei,
pubmed-meshheading:8364872-Leukopenia,
pubmed-meshheading:8364872-Lymphocyte Activation,
pubmed-meshheading:8364872-Middle Aged,
pubmed-meshheading:8364872-Neoplasm Recurrence, Local,
pubmed-meshheading:8364872-Neutropenia,
pubmed-meshheading:8364872-Radiation-Protective Agents,
pubmed-meshheading:8364872-Treatment Outcome,
pubmed-meshheading:8364872-Tuberculin Test,
pubmed-meshheading:8364872-Tumor Markers, Biological,
pubmed-meshheading:8364872-Uterine Cervical Neoplasms
|
pubmed:year |
1993
|
pubmed:articleTitle |
Effect of LC9018 combined with radiation therapy on carcinoma of the uterine cervix. A phase III, multicenter, randomized, controlled study.
|
pubmed:affiliation |
Department of Radiology, Tokyo Women's, Japan.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase II
|